The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125214781 12521478 1 I 20150727 20160624 20160701 20160701 EXP IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-052745 BRISTOL MYERS SQUIBB 54.52 YR M Y 0.00000 20160701 CN IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125214781 12521478 1 PS REYATAZ ATAZANAVIR SULFATE 1 Oral 300 MG, QD 671400 MG 21567 300 MG CAPSULE, HARD QD
125214781 12521478 2 C COMBIVIR LAMIVUDINEIDOVUDINE 1 Unknown UNK U 0 TABLET
125214781 12521478 3 C COMBIVIR LAMIVUDINEIDOVUDINE 1 Unknown UNK U 0 TABLET
125214781 12521478 4 C NORVIR RITONAVIR 1 Oral 100 MG, UNK U 0 100 MG TABLET
125214781 12521478 5 C RAMIPRIL RATIOPHARM 2 Oral 5 MG, UNK U 0 5 MG TABLET
125214781 12521478 6 C DIBASE CHOLECALCIFEROL 1 Oral 1 DF, UNK U 0 1 DF ORAL DROPS, SOLUTION
125214781 12521478 7 C XYZAL LEVOCETIRIZINE DIHYDROCHLORIDE 1 Oral UNK U 0 TABLET
125214781 12521478 8 C KIVEXA ABACAVIR SULFATELAMIVUDINE 1 Oral UNK U 0 TABLET
125214781 12521478 9 C TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral UNK U 0 TABLET
125214781 12521478 10 C LOSARTAN RANBAXY 2 Oral UNK U 0 TABLET
125214781 12521478 11 C ISENTRESS RALTEGRAVIR POTASSIUM 1 Oral 800 MG, UNK U 0 800 MG TABLET
125214781 12521478 12 C ALENDRONATE MYLAN ALENDRONATE SODIUM 1 Oral 70 MG, UNK U 0 70 MG TABLET
125214781 12521478 13 C INTELENCE ETRAVIRINE 1 Unknown 400 MG, UNK U 0 400 MG TABLET
125214781 12521478 14 C DEURSIL URSODIOL 1 Unknown UNK U 0 CAPSULE

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125214781 12521478 1 HIV infection
125214781 12521478 2 HIV infection
125214781 12521478 4 HIV infection
125214781 12521478 5 Hypertension
125214781 12521478 6 Vitamin D deficiency
125214781 12521478 7 Product used for unknown indication
125214781 12521478 8 HIV infection
125214781 12521478 9 HIV infection
125214781 12521478 10 Hypertension
125214781 12521478 11 HIV infection
125214781 12521478 12 Osteoporosis
125214781 12521478 13 HIV infection
125214781 12521478 14 Biliary colic

Outcome of event

Event ID CASEID OUTC COD
125214781 12521478 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125214781 12521478 Bile duct stone
125214781 12521478 Cholelithiasis
125214781 12521478 Hyperbilirubinaemia
125214781 12521478 Hypercalcaemia
125214781 12521478 Hypophosphataemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125214781 12521478 1 20090611 20150727 0
125214781 12521478 2 20061017 20111005 0
125214781 12521478 3 20111209 20120201 0
125214781 12521478 4 20090611 0
125214781 12521478 5 20100521 20130220 0
125214781 12521478 6 20110309 0
125214781 12521478 7 20101206 20110309 0
125214781 12521478 8 20111005 20141209 0
125214781 12521478 9 20120201 20130821 0
125214781 12521478 10 20130220 0
125214781 12521478 11 20130821 20150115 0
125214781 12521478 12 20131113 0
125214781 12521478 13 20150115 0
125214781 12521478 14 20150115 20160505 0